
The ruling forms part of a wider piece of work by the Advertising Standards Authority on ads relating to low testosterone, identified for investigation following complaints and intelligence gathered by its Active Ad Monitoring system, which uses AI to proactively search for online ads that might break the rules.
Voy sells products such as testosterone, menopause and weight loss treatments and is part of the Menwell Group, which has already had six separate campaigns banned by the watchdog over the past 18 months.
All five ads, including posters and Facebook ads, promoted Voy’s at-home testosterone blood tests. They contained phrases including “It’s not him, it’s his hormones”, “Low sex drive? Lost his spark?” and “Feeling irritable? It might be low testosterone”.
In its defence, Voy insisted that the language used in the ads was deliberately conditional, using claims such as “might be” and “might have” to indicate a possible cause of the common symptoms and avoided causal or diagnostic claims.
The ASA, however, took issue with how some of the ads “referenced symptoms and characteristics that in isolation were common and could arise for many reasons, we considered that they exaggerated the likely connection between them and low testosterone levels and were therefore misleading”.
Banning the ads from appearing again, the watchdog went on to warn Voy about its future conduct.
The ruling follows two others in August, which found misleading claims in ads for testosterone testing services from online providers BioID Health and Numan Digital Healthcare.
Related stories
Healthcare firms cut down to size over testosterone ads
Major travel brands sent packing over ‘eco’ ad claims
ASA buries The Mummy poster over ‘dead child’ image
Pure Cremation ad scorched for misleading consumers
We are not amused: ASA pours booze ads down the drain


Be the first to comment on "Ad watchdog issues stiff rebuke for testosterone ads"